Extended Deadline for Abstract Submission

The deadline to submit an abstract to the 2nd International Forum on COVID Rehabilitation Research has been extended until Friday February 16^th, 2024. Submit your abstract now to share your COVID rehabilitation research!

The Rehabilitation Science Research Network for COVID (the Network) is hosting the 2024 International Forum on COVID Rehabilitation Research on Friday April 19th. The aim of this forum is to advance knowledge transfer and exchange, collaborations and partnerships in COVID rehabilitation research in practice among persons with lived experiences, caregivers, researchers, clinicians, educators, trainees, representatives from community organizations, and policy stakeholders with an interest in COVID-19 rehabilitation research. The Forum will be held virtually (via Zoom) and in-person at the Rehabilitation Sciences Building, 500 University Avenue (Room 140), Toronto.

The Network Forum committee invites abstracts for in-person or online poster presentations at the upcoming 2024 International Forum on COVID Rehabilitation Research. Abstracts should align with at least one of the following themes, based on the Framework of Research Priorities in COVID Rehabilitation:

1. Understanding experiences of episodic disability;
2. Assessing episodic disability;
3. Identifying and examining safe approaches to rehabilitation;
4. Examining the role, implementation, and impact of models of rehabilitation care; or
5. Examining access to safe, timely and appropriate rehabilitation and other health care provider services.
6. Methodological considerations in COVID rehabilitation research

The new deadline for abstract submission is Friday February 16^th, 2024.

How to Submit an Abstract

Please carefully read the abstract submission guidelines and policies prior to submitting your abstract here.

If you have any questions, please contact the Program Coordinator, Kiera McDuff, at rehab.covid@utoronto.ca!

Acknowledgements

The Rehabilitation Science Research Network for COVID is funded by Temerty Faculty of Medicine, University of Toronto.